Journal article
Authors list: Grau, Veronika; Wilker, Sigrid; Lips, Katrin S.; Hartmann, Petra; Rose, Frank; Padberg, Winfried; Fehrenbach, Heinz; Wessler, Ignatz; Kummer, Wolfgang
Publication year: 2007
Pages: 1955-1963
Journal: The International Journal of Biochemistry and Cell Biology
Volume number: 39
Issue number: 10
ISSN: 1357-2725
eISSN: 1878-5875
DOI Link: https://doi.org/10.1016/j.biocel.2007.05.017
Publisher: Elsevier
Abstract:
Keratinocyte growth factor protects the lung against various injurious stimuli. The protective mechanisms, however, are not yet fully understood. The aim of this study is to determine the influence of keratinocyte growth factor on the pulmonary capacity to synthesize acetylcholine, a potent regulator of pulmonary functions which is potentially involved in lung damage. Rats were treated twice (days I and 2) intratracheally with keratinocyte growth factor and analyzed at day 4. The mRNA expression of choline acetyltransferase - the acetylcholine synthesizing enzyme - was analyzed by real-time RT-PCR in the lung and in isolated alveolar epithelial type II cells. Choline acetyltransferase protein was assessed by immunoblotting and immunohistochemistry. Finally, pulmonary acetylcholine content was assessed biochemically. Keratinocyte growth factor-treatment led to decreased levels of choline acetyltransferase mRNA in the lung and in isolated alveolar epithelial type II cells. Accordingly, pulmonary choline acetyltransferase protein levels were reduced and pulmonary acetylcholine content declined from 2.8 nmol (control) to 0.4 nmol acetylcholine per gram of wet weight. In conclusion, the present data show that the potent regulator of pulmonary functions, acetylcholine, is produced by the major pulmonary target cell of keratinocyte growth factor, that is alveolar epithelial type II cells. Acetylcholine synthesis is down-regulated by keratinocyte growth factor administration which might contribute to lung protection and to harmonize surfactant homeostasis under conditions of keratinocyte growth factor-induced alveolar epithelial type II cell hyperplasia. (c) 2007 Elsevier Ltd. All rights reserved.
Citation Styles
Harvard Citation style: Grau, V., Wilker, S., Lips, K., Hartmann, P., Rose, F., Padberg, W., et al. (2007) Administration of keratinocyte growth factor down-regulates the pulmonary capacity of acetylcholine production, The International Journal of Biochemistry and Cell Biology, 39(10), pp. 1955-1963. https://doi.org/10.1016/j.biocel.2007.05.017
APA Citation style: Grau, V., Wilker, S., Lips, K., Hartmann, P., Rose, F., Padberg, W., Fehrenbach, H., Wessler, I., & Kummer, W. (2007). Administration of keratinocyte growth factor down-regulates the pulmonary capacity of acetylcholine production. The International Journal of Biochemistry and Cell Biology. 39(10), 1955-1963. https://doi.org/10.1016/j.biocel.2007.05.017
Keywords
AFFINITY CHOLINE TRANSPORTER; ALVEOLAR; choline acetyltransferase; high-affinity choline transporter; HYPERPLASIA; II EPITHELIAL-CELLS; keratinocyte growth factor; KGF; Non-neuronal acetylcholine; Trachea